1. Home
  2. CSGP vs ILMN Comparison

CSGP vs ILMN Comparison

Compare CSGP & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CoStar Group Inc.

CSGP

CoStar Group Inc.

HOLD

Current Price

$38.90

Market Cap

21.1B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$131.40

Market Cap

19.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSGP
ILMN
Founded
1987
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.1B
19.4B
IPO Year
1998
2000

Fundamental Metrics

Financial Performance
Metric
CSGP
ILMN
Price
$38.90
$131.40
Analyst Decision
Buy
Hold
Analyst Count
14
17
Target Price
$69.14
$124.24
AVG Volume (30 Days)
5.6M
1.2M
Earning Date
04-28-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
170.87
EPS
0.02
5.45
Revenue
$965,230,000.00
$4,343,000,000.00
Revenue This Year
$19.71
$6.47
Revenue Next Year
$12.40
$5.58
P/E Ratio
$1,997.00
$24.43
Revenue Growth
15.23
N/A
52 Week Low
$34.75
$73.86
52 Week High
$97.43
$155.53

Technical Indicators

Market Signals
Indicator
CSGP
ILMN
Relative Strength Index (RSI) 40.84 56.39
Support Level $34.75 $127.99
Resistance Level $49.03 $136.86
Average True Range (ATR) 1.75 5.00
MACD 0.45 0.89
Stochastic Oscillator 63.38 67.23

Price Performance

Historical Comparison
CSGP
ILMN

About CSGP CoStar Group Inc.

CoStar Group is a leading provider of commercial real estate data and marketplace listing platforms. Its data offering contains in-depth analytical information on over 5 million commercial real estate properties related to various subsectors spanning office, retail, hotels, multifamily, healthcare, industrial, self-storage, and data centers. It operates many well-respected brands such as CoStar Suite, LoopNet, Apartments.com, BizBuySell, and Lands of America, with more than 80% of its revenue classified as subscription-based. The company recently expanded its presence into Canada, the United Kingdom, Spain, and France.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: